dalbavancin

Known as: dalbavancin [Chemical/Ingredient], Ristomycin A Aglycone, 5,31-Dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-O-(2-deoxy-2-((10-methyl-1-oxoundecyl)amino)-beta-D-glucopyranuronosyl)-38-(((3-(dimethylamino)propyl)amino)carbonyl)-42-O-alpha-D-mannopyranosyl-N15-methyl-, dalbavancin B0 
A second-generation, semi-synthetic lipoglycopeptide antibiotic, with bactericidal activity against a variety of gram-positive bacteria. Upon… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
BACKGROUND Dalbavancin, a lipoglycopeptide antibiotic agent that is active against gram-positive pathogens, has a long plasma… (More)
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2009
Review
2009
Antibiotic resistance is a major public health concern, with fears expressed that we shortly will run out of antibiotics. In… (More)
Is this relevant?
Review
2007
Review
2007
The increasing incidence of serious infections because of Gram-positive pathogens and the rising cost in parenteral… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 1
Is this relevant?
2006
2006
OBJECTIVES The antibacterial effect of dalbavancin was studied against Staphylococcus aureus using stepwise declining… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Dalbavancin, a novel lipoglycopeptide with a pharmacokinetic profile that allows weekly dosing, is active against gram… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2005
2005
Dalbavancin, tested against 146 staphylococci, was more potent than other drugs tested, with an MIC at which 50% of staphylococci… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2005
Review
2005
Dalbavancin is a novel semi-synthetic lipoglycopeptide that was designed to improve upon the natural glycopeptides currently… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Catheter-related bloodstream infections (CR-BSIs) are associated with substantial mortality, prolongation of hospital… (More)
Is this relevant?
2004
2004
Fifty-two healthy adult male and female volunteers were enrolled in this double-blind study to determine the maximum tolerated… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Dalbavancin, a novel glycopeptide with a long elimination half-life ( approximately 9-12 days), was compared to standard… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?